Accutar Biotechnology Announces FDA Clearance of IND Application for Phase 1 Trial of AC0676 in B-cell Malignancies
CRANBURY, N.J.–(BUSINESS WIRE)–Accutar Biotechnology, Inc., a biotechnology company focusing on artificial intelligence (AI)-empowered drug discovery,…
ZenaTech Unveils its Proprietary AI Software Suite Designed to Accelerate Land Survey Delivery for Drone as a Service Commercial, Municipal and Infrastructure Clients
GA-ASI Partnering With Spirit Defense For FQ-42 CCA Production
Study Finds Lower Rates of Overweight Among Vegan-Fed Cats
Savills Hong Kong Hosts Grand Reception to Celebrate 40th Anniversary, Over 300 Guests Gather to Mark Glorious Milestone
PatientGain Launches ReputeMD: A HIPAA-Compliant Online Reputation Management Service for Doctors and Dentists